The study aims to evaluate public preferences for statin therapy by measuring willingness based on expected benefits and burdens.
Conducted a survey assessing willingness to take statins
Included participants from the US and Japan
Evaluated expected risk-reduction benefits and associated burdens
Individuals showed varying willingness based on perceived benefits
Differences in preferences observed between US and Japanese participants
Expected risk-reduction benefits significantly influenced willingness to take statins
Abstract
This survey study uses the smallest worthwhile difference to assess US and Japanese individuals’ willingness to take statins based on expected risk-reduction benefits and burden.